NDRA ENDRA Life Sciences Inc

Price (delayed)

$4.82

Market cap

$6.12M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$8.15

Enterprise value

$6.72M

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 7

ENDRA Life Sciences is the pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), a ground-breaking technology being developed to visualize tissue like MRI, but at 1/50th the cost and at the ...

Highlights
The debt has decreased by 2.9% YoY and by 2.3% from the previous quarter
The company's EPS has shrunk by 159% YoY but it rose by 9% QoQ
ENDRA Life Sciences's net income has increased by 25% YoY but it has decreased by 3.9% from the previous quarter
The company's quick ratio has shrunk by 88% YoY and by 58% QoQ
NDRA's equity is down by 21% since the previous quarter

Key stats

What are the main financial stats of NDRA

NDRA stock price

How has the ENDRA Life Sciences stock price performed over time
Intraday
1.9%
1 week
-12.68%
1 month
-2.43%
1 year
35.39%
YTD
6.4%
QTD
3.66%

Financial performance

How have ENDRA Life Sciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$6.47M
Net income
-$7.3M
Gross margin
N/A
Net margin
N/A
The operating income rose by 32% year-on-year but it has declined by 12% since the previous quarter
ENDRA Life Sciences's net income has increased by 25% YoY but it has decreased by 3.9% from the previous quarter

Price vs fundamentals

How does NDRA's price correlate with its fundamentals

Growth

What is ENDRA Life Sciences's growth rate over time

Valuation

What is ENDRA Life Sciences stock price valuation
P/E
N/A
P/B
3.35
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS has shrunk by 159% YoY but it rose by 9% QoQ
NDRA's P/B is 57% less than its last 4 quarters average of 7.7 but 2.5% more than its 5-year quarterly average of 3.2
NDRA's equity is down by 21% since the previous quarter

Efficiency

How efficient is ENDRA Life Sciences business performance
The return on equity has dropped by 162% year-on-year and by 3.3% since the previous quarter
The ROA has dropped by 64% year-on-year
The company's return on invested capital rose by 16% YoY and by 15% QoQ

Dividends

What is NDRA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NDRA.

Financial health

How did ENDRA Life Sciences financials performed over time
NDRA's total assets is 108% greater than its total liabilities
The company's quick ratio has shrunk by 88% YoY and by 58% QoQ
ENDRA Life Sciences's current ratio has shrunk by 83% YoY and by 50% QoQ
The debt is 47% less than the equity
The debt to equity has increased by 23% QoQ but it has decreased by 5% YoY
NDRA's equity is down by 21% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.